Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

TM Halsey, AS Thomas, T Hayase, W Ma… - Science translational …, 2023 - science.org
Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also
predispose patients to immune-related adverse events like immune-mediated colitis (IMC) …

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis

TM Halsey, AS Thomas, T Hayase… - Science …, 2023 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also
predispose patients to immune-related adverse events like immune-mediated colitis (IMC) …

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

TM Halsey, AS Thomas… - Science …, 2023 - mdanderson.elsevierpure.com
Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also
predispose patients to immune-related adverse events like immune-mediated colitis (IMC) …

[HTML][HTML] Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

TM Halsey, AS Thomas, T Hayase, W Ma… - Science translational …, 2023 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also
predispose patients to immune-related adverse events, such as immune-mediated colitis …

[PDF][PDF] Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

TM Halsey, AS Thomas, T Hayase, W Ma, H Abu-Sbeih… - 2023 - kelseyresearch.com
Immune checkpoint inhibitor (ICI) therapies are oncologic treatment strategies that promote
an antitumor response by impairing inhibitory T cell pathways. ICIs enhance immune …

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis.

TM Halsey, AS Thomas, T Hayase… - Science …, 2023 - search.ebscohost.com
Immune checkpoint inhibitors (ICIs) target advanced malignancies with high efficacy but also
predispose patients to immune-related adverse events like immune-mediated colitis (IMC) …